SCHEMBL16640335

SCHEMBL16640335

CC(C)c1ccc(-n2c3ccccc3c3cnccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.47
MAOB P27338 4/20 0.47
ACHE P22303 1/20 0.47
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP2D6 P10635 1/20 0.44
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
PTPN1 P18031 1/20 0.39
NOTUM Q6P988 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TOP2A P11388 1/20 0.36
KDR P35968 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16640317 0.91 KDM4E (0.44) MAOAMAOBACHEKDM4EATM
SCHEMBL12383089 0.86 RXFP1 (0.47) MAOAMAOBACHEKDM4EATM
SCHEMBL1102414 0.86 KDM4E (0.59) KDM4EATML3MBTL1PTPN1NOTUM
SCHEMBL11978692 0.83 MAOA (0.50) MAOAMAOBACHEKDM4EATM
SCHEMBL4570443 0.83 MAOA (0.53) MAOAMAOBACHEKDM4EATM
SCHEMBL15907062 0.83 MAOA (0.53) MAOAMAOBACHEKDM4EATM
SCHEMBL12098614 0.82 KDM4E (0.67) MAOAMAOBACHEKDM4EATM
SCHEMBL16640323 0.82 MAOA (0.43) MAOAMAOBACHEKDM4EATM
SCHEMBL16640315 0.82 MAOA (0.43) MAOAMAOBACHECYP2D6DDB1
SCHEMBL9916266 0.81 KDM4E (0.53) KDM4EATML3MBTL1PTPN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11189808-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-11-30 US disclosed
US-20200152891-A1 PLATINUM COMPLEXES AND DEVICES UNIV ARIZONA STATE (US) 2020-05-14 US disclosed
US-10566553-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-02-18 US disclosed
US-9947881-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-17 US disclosed
US-9947881-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-17 US disclosed
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-01-12 US disclosed
US-9385329-B2 Platinum complexes and devices Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation (US) 2016-07-05 US disclosed
US-20150105556-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11189808-B2 Platinum complexes and devices OXA1L, OCIAD1, OCIAD2 MAOA 1850/4885MAOB 1214/4885ACHE 3544/4885
US-10566553-B2 Platinum complexes and devices OXA1L, OCIAD1, OCIAD2 MAOA 1850/4885MAOB 1214/4885ACHE 3544/4885
US-20200152891-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 MAOA 1850/4885MAOB 1214/4885ACHE 3544/4885
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 MAOA 1850/4885MAOB 1214/4885ACHE 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.